Sarah H. Nash

ORCID: 0000-0002-9038-6001 · 1 paper in corpus

letter 2022

Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers‡

The Journal of Pathology ·doi:10.1002/path.5973

The ARID1A tumour suppressor protein is a component of the SWI/SNF chromatin remodelling complex, which is mutated in approximately 20% of all human cancers. ARID1A mutational status is considered to hold prognostic significance in a range …